Olive oil is often sold on its polyphenols, and "high-phenolic" bottles cost more. A small pilot trial in older adults asked a more careful question: does extra-virgin olive oil raise the antioxidant capacity of the blood, does extra phenolic content add anything, and does it matter who is eating it? The answer was mixed, and the study is very small.
What was tested
Thirty-four older adults (73.1 ± 5.9 years; 65% men) took part in this pilot randomized trial. Some were healthy controls and some had previously had a myocardial infarction (post-MI). For 26 weeks each person consumed 25 mL a day of one of three oils: standard extra-virgin olive oil (EVOO), an EVOO enriched with tyrosol and hydroxytyrosol (HP-EVOO), or refined olive oil (ROO), which has lost most of its phenolic compounds.
The outcome was plasma total antioxidant capacity (TEAC), a laboratory measure of how well a blood sample neutralizes oxidants. Baseline adherence to a Mediterranean diet (MedDiet) came from 3-day food diaries and was sorted into low or high.
What changed, and for whom
Within the standard EVOO group, TEAC rose more in post-MI participants than in healthy controls: +402 μM (95% CI 162-641). Also within the EVOO group, people with high baseline MedDiet adherence had a larger rise than those with low adherence: +274 μM (95% CI 1.6-545).
The high-phenolic oil did not do better. No significant between-group TEAC differences were observed after HP-EVOO or ROO. In other words, adding more phenolics did not enhance the response, which the authors describe as context-dependent rather than driven by phenolic concentration alone.
How much weight these numbers can carry
- Very small sample. With 34 people split by oil type, heart-attack history and diet adherence, each subgroup is tiny. The abstract does not report group sizes.
- Wide, borderline intervals. The MedDiet result has a confidence interval running from 1.6 to 545, so it barely excludes no difference.
- Subgroup contrasts, not an overall effect. Both headline figures compare subgroups inside the EVOO arm. They do not show that EVOO beat refined olive oil overall.
- A lab marker, not an outcome. TEAC is an antioxidant-capacity measure. The trial did not test heart attacks, blood pressure or survival, and a higher TEAC is not shown here to mean better health.
- Self-reported diet. Adherence was estimated from three days of food records.
The authors themselves call for larger trials. The published declaration states no potential conflicts of interest; we did not verify the funding source from the abstract.
Our reading: the useful takeaway is modest. Paying more for a high-phenolic label is not supported by this trial, and the antioxidant response to olive oil seems to vary with the person and their overall diet. That is a hypothesis for a bigger study, not a reason to change what you eat.
This article is for general education and is not medical advice.